Drug Research

Dragonfly Therapeutics announced a strategic collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to discover, develop and commercialize…
Read More...

Emergex Vaccines Holding Limited announces that it has signed a Memorandum of Understanding (MoU) with Brazil-based Oswaldo Cruz Foundation ‘Fiocruz’ for the development of viral…
Read More...

Halozyme Therapeutics announced that Roche has received approval from Health Canada for a subcutaneous (SC) formulation of trastuzumab (Herceptin SC) for the treatment of patients with…
Read More...

LEO Pharma A/S and MorphoSys AG announced an expansion of their existing strategic alliance to include peptide-derived therapeutics. The objective of the alliance is to identify novel,…
Read More...

Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. announced data showing ZTlido (lidocaine topical system) 1.8% (ZTlido) demonstrated a statistically…
Read More...

AstraZeneca and its partner Amgen Inc. announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe…
Read More...

NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy. NHS England chief executive Simon Stevens has announced today that children and young…
Read More...

Atara Biotherapeutics announced that it has entered into a strategic collaboration with Moffitt Cancer Center to develop multi‑targeted chimeric antigen receptor T-cell (CAR T)…
Read More...

AMRI and Metrion Biosciences announced that they have signed a new collaboration agreement. The alliance will promote Metrion's electrophysiology and ion channel screening expertise to…
Read More...

REGENXBIO Inc. announced that it is developing a new product candidate, RGX-181, for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease, one of the…
Read More...

Trovagene announced that the European Commission (EC) has endorsed the positive opinion of the Committee for Orphan Medicinal Products (COMP) and has granted Orphan Drug Designation…
Read More...

Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development. Through this partnership, both companies…
Read More...

Evotec AG announced that CENTOGENE AG and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic…
Read More...

Adverum Biotechnologies announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ADVM-053, a preclinical gene therapy candidate…
Read More...

JW Pharmaceutical and LEO Pharma A/S announced that they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601, under which, LEO Pharma, a…
Read More...

Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical company, exploring the potential of combination therapy…
Read More...

Roche announced that the China National Drug Administration (CNDA) has granted marketing authorisation for Alecensa (alectinib) as a monotherapy treatment for patients with anaplastic…
Read More...

AstraZeneca announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Tagrisso(osimertinib) for the 1st-line treatment of patients with inoperable or…
Read More...

Revive Therapeutics Ltd. announced that it has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation of cannabidiol for the treatment of…
Read More...

Structured Immunity and Medigene announced a research collaboration where Structured Immunity will provide structural immunology expertise in support of Medigene's TCR discovery…
Read More...